pyrazinamide has been researched along with Erysipelas in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Erysipelas: An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sattinger, E | 1 |
| Meyer, S | 1 |
| Costard-Jäckle, A | 1 |
1 other study available for pyrazinamide and Erysipelas
| Article | Year |
|---|---|
Cutaneous tuberculosis mimicking erysipelas of the lower leg in a heart transplant recipient.
Topics: Antitubercular Agents; Erysipelas; Ethambutol; Heart Transplantation; Humans; Isoniazid; Leg; Opport | 2011 |